Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells
- 27 July 2004
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 130 (10), 567-573
- https://doi.org/10.1007/s00432-004-0582-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasisBiochemical and Biophysical Research Communications, 2002
- Hypoxic induction of HIF-1α and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinasesOral Oncology, 2002
- The Roles of JNK1 and Stat3 in the Response of Head and Neck Cancer Cell Lines to Combined Treatment with All trans‐retinoic Acid and 5‐FluorouracilJapanese Journal of Cancer Research, 2002
- Angiotensin-I-Converting Enzyme Inhibitors May Be an Alternative Anti-Angiogenic Strategy in the Treatment of Liver Fibrosis and Hepatocellular CarcinomaTumor Biology, 2002
- CLINICAL RESEARCH ON ANTIANGIOGENIC THERAPYPharmacological Research, 1998
- Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinomaOral Oncology, 1997
- Mechanisms of angiogenesisNature, 1997
- Endothelial receptor tyrosine kinases involved in angiogenesis.The Journal of cell biology, 1995
- The Expanding Role of Angiotensin Converting Enzyme Inhibitors in the Management of HypertensionThe Journal of Clinical Pharmacology, 1995
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990